Calcium‐ and Tyrosine Kinase‐Dependent Suppression of Macroscopic Homomeric Kv1.2 and Heteromeric Kv1.1/1.2 current by Amyloid Beta (1‐42) Peptide: Implications for Alzheimer’s Disease
Background The roles of Aβ in the pathogenesis of Alzheimer ’s disease (AD) include disruption of synaptic communication/function and synaptic plasticity mechanisms thought to underlie learning and memory. Exactly how these abnormal processes arise is incompletely understood, but evidence suggests t...
Gespeichert in:
Veröffentlicht in: | Alzheimer's & dementia 2024-12, Vol.20 (S1), p.n/a |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | n/a |
---|---|
container_issue | S1 |
container_start_page | |
container_title | Alzheimer's & dementia |
container_volume | 20 |
creator | Jamshidi, Dina Yaklin, Logen Burch, Sebastian DeBoeuf, Kristi Farley, Joseph |
description | Background
The roles of Aβ in the pathogenesis of Alzheimer ’s disease (AD) include disruption of synaptic communication/function and synaptic plasticity mechanisms thought to underlie learning and memory. Exactly how these abnormal processes arise is incompletely understood, but evidence suggests that dysregulation of intracellular Ca2+ levels is involved in alterations of neuronal excitability, synaptic remodeling, and neurodegeneration in AD. Our lab has focused on the potential involvement of voltage‐gated potassium channels (VGKCs) in these processes, particularly Kv1.x family members. VGKCs contribute to resting membrane potential, regulate Ca2+ influx, and their inhibition may lead to and synapto‐ and neuro‐toxicity through hyperexcitability and excess glutamate release. Kv1.x family members are expressed as homotetramers, or as select heterotetramers (e.x Kv1.1/1.2) contributing to the diversity of electrical signaling. Previously, we have observed rapid and robust suppression (50% in 30 minutes) of macroscopic current by Aβ(1‐42) in homomeric Kv1.1 expressing Xenopus laevis oocytes. We sought to understand 1) if suppression by Aβ(1‐42) is exclusive to Kv1.1, or is able to affect other Kv1.x members such as homomeric Kv1.2 and heteromeric Kv1.1/1.2 channels 2) The extent to which the suppression is Ca2+ dependent, and 3) whether the suppression is additionally dependent on endogenous tyrosine kinase activity.
Method
Stage V/VI Xenopus laevis oocytes were injected with Kv1.2 cRNA or both Kv1.1 and 1.2 cRNA for homomeric and heteromeric expression respectively. The effects of bath application of 1 μM of Aβ(1‐42) were evaluated using two‐electrode voltage clamp electrophysiology (TEVC), and Ca2+ dependency was evaluated using BAPTA‐AM (a Ca2+ chelator) and Cyclosporin A (CsA; a PP2B inhibitor). Oocytes were additionally incubated in genistein, a non‐specific tyrosine kinase inhibitor.
Result
For both homo‐and heteromeric channel expressing oocytes, incubation in BAPTA‐AM significantly reduced suppression by ∼45%, while incubation with CsA blocked any suppressive effects of Aβ(1‐42). Oocytes incubated in genistein significantly blocked Aβ‐suppression at a level greater than CsA and BAPTA‐AM (>98%).
Conclusion
Reducing intracellular Ca2+ and inhibiting Ca2+ activated signaling molecules such as PP2B and tyrosine kinases reduces suppression of macroscopic Kv1.x current by Aβ(1‐42). |
doi_str_mv | 10.1002/alz.087563 |
format | Article |
fullrecord | <record><control><sourceid>wiley_pubme</sourceid><recordid>TN_cdi_wiley_primary_10_1002_alz_087563_ALZ087563</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ALZ087563</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1693-81c01b7dd9a5335723e429028bea375ca645f4c7d683c2772a71cc23474812813</originalsourceid><addsrcrecordid>eNp9kcFOGzEQhlcVSIXQC0_gY6mU4LHX6w2XKk2gQQQVCbj0Yjne2eJqd72yN1TLiUfgytv0WXgSHIJQe-E0o5l_vrHnT5J9oCOglB3q6m5Ecyky_iHZASHYUDA53nrLM_ox2Q3hN6UpzUHsJH-nujJ2VT_dPxDdFOSq9y7YBsmZbXTAWJ5hi02BTUcuV23rMQTrGuJKcq5N1BrXWkPmrnY1-pid3cKIvaDm2KH_pwqH645Zeb-GLXsyqfvK2YJ8w06TzxB3peyAXGDb2QKPyGndVtboLq4LpHSeTKq7G7QR-HT_GMjMBowv3Eu2S10F_PQaB8n1yfHVdD5c_Ph-Op0shgayMR_mYCgsZVGMteBcSMYxZWPK8iVqLoXRWSrK1Mgiy7lhUjItwRjGU5nmwHLgg-TrhtuuljUWJv7B60q13tba98ppq_7vNPZG_XK3CkACBZpGwpcNYX224LF8Gwaq1u6p6J7auBfFsBH_sRX27yjVZPHzdeYZpO-h2Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Calcium‐ and Tyrosine Kinase‐Dependent Suppression of Macroscopic Homomeric Kv1.2 and Heteromeric Kv1.1/1.2 current by Amyloid Beta (1‐42) Peptide: Implications for Alzheimer’s Disease</title><source>Wiley Online Library Open Access</source><source>Wiley Online Library Journals Frontfile Complete</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Jamshidi, Dina ; Yaklin, Logen ; Burch, Sebastian ; DeBoeuf, Kristi ; Farley, Joseph</creator><creatorcontrib>Jamshidi, Dina ; Yaklin, Logen ; Burch, Sebastian ; DeBoeuf, Kristi ; Farley, Joseph</creatorcontrib><description>Background
The roles of Aβ in the pathogenesis of Alzheimer ’s disease (AD) include disruption of synaptic communication/function and synaptic plasticity mechanisms thought to underlie learning and memory. Exactly how these abnormal processes arise is incompletely understood, but evidence suggests that dysregulation of intracellular Ca2+ levels is involved in alterations of neuronal excitability, synaptic remodeling, and neurodegeneration in AD. Our lab has focused on the potential involvement of voltage‐gated potassium channels (VGKCs) in these processes, particularly Kv1.x family members. VGKCs contribute to resting membrane potential, regulate Ca2+ influx, and their inhibition may lead to and synapto‐ and neuro‐toxicity through hyperexcitability and excess glutamate release. Kv1.x family members are expressed as homotetramers, or as select heterotetramers (e.x Kv1.1/1.2) contributing to the diversity of electrical signaling. Previously, we have observed rapid and robust suppression (50% in 30 minutes) of macroscopic current by Aβ(1‐42) in homomeric Kv1.1 expressing Xenopus laevis oocytes. We sought to understand 1) if suppression by Aβ(1‐42) is exclusive to Kv1.1, or is able to affect other Kv1.x members such as homomeric Kv1.2 and heteromeric Kv1.1/1.2 channels 2) The extent to which the suppression is Ca2+ dependent, and 3) whether the suppression is additionally dependent on endogenous tyrosine kinase activity.
Method
Stage V/VI Xenopus laevis oocytes were injected with Kv1.2 cRNA or both Kv1.1 and 1.2 cRNA for homomeric and heteromeric expression respectively. The effects of bath application of 1 μM of Aβ(1‐42) were evaluated using two‐electrode voltage clamp electrophysiology (TEVC), and Ca2+ dependency was evaluated using BAPTA‐AM (a Ca2+ chelator) and Cyclosporin A (CsA; a PP2B inhibitor). Oocytes were additionally incubated in genistein, a non‐specific tyrosine kinase inhibitor.
Result
For both homo‐and heteromeric channel expressing oocytes, incubation in BAPTA‐AM significantly reduced suppression by ∼45%, while incubation with CsA blocked any suppressive effects of Aβ(1‐42). Oocytes incubated in genistein significantly blocked Aβ‐suppression at a level greater than CsA and BAPTA‐AM (>98%).
Conclusion
Reducing intracellular Ca2+ and inhibiting Ca2+ activated signaling molecules such as PP2B and tyrosine kinases reduces suppression of macroscopic Kv1.x current by Aβ(1‐42).</description><identifier>ISSN: 1552-5260</identifier><identifier>EISSN: 1552-5279</identifier><identifier>DOI: 10.1002/alz.087563</identifier><language>eng</language><publisher>Hoboken: John Wiley and Sons Inc</publisher><subject>Basic Science and Pathogenesis</subject><ispartof>Alzheimer's & dementia, 2024-12, Vol.20 (S1), p.n/a</ispartof><rights>2024 The Alzheimer's Association. published by Wiley Periodicals LLC on behalf of Alzheimer's Association.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11710104/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11710104/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,1411,11541,27901,27902,45550,45551,46027,46451,53766,53768</link.rule.ids></links><search><creatorcontrib>Jamshidi, Dina</creatorcontrib><creatorcontrib>Yaklin, Logen</creatorcontrib><creatorcontrib>Burch, Sebastian</creatorcontrib><creatorcontrib>DeBoeuf, Kristi</creatorcontrib><creatorcontrib>Farley, Joseph</creatorcontrib><title>Calcium‐ and Tyrosine Kinase‐Dependent Suppression of Macroscopic Homomeric Kv1.2 and Heteromeric Kv1.1/1.2 current by Amyloid Beta (1‐42) Peptide: Implications for Alzheimer’s Disease</title><title>Alzheimer's & dementia</title><description>Background
The roles of Aβ in the pathogenesis of Alzheimer ’s disease (AD) include disruption of synaptic communication/function and synaptic plasticity mechanisms thought to underlie learning and memory. Exactly how these abnormal processes arise is incompletely understood, but evidence suggests that dysregulation of intracellular Ca2+ levels is involved in alterations of neuronal excitability, synaptic remodeling, and neurodegeneration in AD. Our lab has focused on the potential involvement of voltage‐gated potassium channels (VGKCs) in these processes, particularly Kv1.x family members. VGKCs contribute to resting membrane potential, regulate Ca2+ influx, and their inhibition may lead to and synapto‐ and neuro‐toxicity through hyperexcitability and excess glutamate release. Kv1.x family members are expressed as homotetramers, or as select heterotetramers (e.x Kv1.1/1.2) contributing to the diversity of electrical signaling. Previously, we have observed rapid and robust suppression (50% in 30 minutes) of macroscopic current by Aβ(1‐42) in homomeric Kv1.1 expressing Xenopus laevis oocytes. We sought to understand 1) if suppression by Aβ(1‐42) is exclusive to Kv1.1, or is able to affect other Kv1.x members such as homomeric Kv1.2 and heteromeric Kv1.1/1.2 channels 2) The extent to which the suppression is Ca2+ dependent, and 3) whether the suppression is additionally dependent on endogenous tyrosine kinase activity.
Method
Stage V/VI Xenopus laevis oocytes were injected with Kv1.2 cRNA or both Kv1.1 and 1.2 cRNA for homomeric and heteromeric expression respectively. The effects of bath application of 1 μM of Aβ(1‐42) were evaluated using two‐electrode voltage clamp electrophysiology (TEVC), and Ca2+ dependency was evaluated using BAPTA‐AM (a Ca2+ chelator) and Cyclosporin A (CsA; a PP2B inhibitor). Oocytes were additionally incubated in genistein, a non‐specific tyrosine kinase inhibitor.
Result
For both homo‐and heteromeric channel expressing oocytes, incubation in BAPTA‐AM significantly reduced suppression by ∼45%, while incubation with CsA blocked any suppressive effects of Aβ(1‐42). Oocytes incubated in genistein significantly blocked Aβ‐suppression at a level greater than CsA and BAPTA‐AM (>98%).
Conclusion
Reducing intracellular Ca2+ and inhibiting Ca2+ activated signaling molecules such as PP2B and tyrosine kinases reduces suppression of macroscopic Kv1.x current by Aβ(1‐42).</description><subject>Basic Science and Pathogenesis</subject><issn>1552-5260</issn><issn>1552-5279</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNp9kcFOGzEQhlcVSIXQC0_gY6mU4LHX6w2XKk2gQQQVCbj0Yjne2eJqd72yN1TLiUfgytv0WXgSHIJQe-E0o5l_vrHnT5J9oCOglB3q6m5Ecyky_iHZASHYUDA53nrLM_ox2Q3hN6UpzUHsJH-nujJ2VT_dPxDdFOSq9y7YBsmZbXTAWJ5hi02BTUcuV23rMQTrGuJKcq5N1BrXWkPmrnY1-pid3cKIvaDm2KH_pwqH645Zeb-GLXsyqfvK2YJ8w06TzxB3peyAXGDb2QKPyGndVtboLq4LpHSeTKq7G7QR-HT_GMjMBowv3Eu2S10F_PQaB8n1yfHVdD5c_Ph-Op0shgayMR_mYCgsZVGMteBcSMYxZWPK8iVqLoXRWSrK1Mgiy7lhUjItwRjGU5nmwHLgg-TrhtuuljUWJv7B60q13tba98ppq_7vNPZG_XK3CkACBZpGwpcNYX224LF8Gwaq1u6p6J7auBfFsBH_sRX27yjVZPHzdeYZpO-h2Q</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Jamshidi, Dina</creator><creator>Yaklin, Logen</creator><creator>Burch, Sebastian</creator><creator>DeBoeuf, Kristi</creator><creator>Farley, Joseph</creator><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>202412</creationdate><title>Calcium‐ and Tyrosine Kinase‐Dependent Suppression of Macroscopic Homomeric Kv1.2 and Heteromeric Kv1.1/1.2 current by Amyloid Beta (1‐42) Peptide: Implications for Alzheimer’s Disease</title><author>Jamshidi, Dina ; Yaklin, Logen ; Burch, Sebastian ; DeBoeuf, Kristi ; Farley, Joseph</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1693-81c01b7dd9a5335723e429028bea375ca645f4c7d683c2772a71cc23474812813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Basic Science and Pathogenesis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jamshidi, Dina</creatorcontrib><creatorcontrib>Yaklin, Logen</creatorcontrib><creatorcontrib>Burch, Sebastian</creatorcontrib><creatorcontrib>DeBoeuf, Kristi</creatorcontrib><creatorcontrib>Farley, Joseph</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Alzheimer's & dementia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jamshidi, Dina</au><au>Yaklin, Logen</au><au>Burch, Sebastian</au><au>DeBoeuf, Kristi</au><au>Farley, Joseph</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Calcium‐ and Tyrosine Kinase‐Dependent Suppression of Macroscopic Homomeric Kv1.2 and Heteromeric Kv1.1/1.2 current by Amyloid Beta (1‐42) Peptide: Implications for Alzheimer’s Disease</atitle><jtitle>Alzheimer's & dementia</jtitle><date>2024-12</date><risdate>2024</risdate><volume>20</volume><issue>S1</issue><epage>n/a</epage><issn>1552-5260</issn><eissn>1552-5279</eissn><abstract>Background
The roles of Aβ in the pathogenesis of Alzheimer ’s disease (AD) include disruption of synaptic communication/function and synaptic plasticity mechanisms thought to underlie learning and memory. Exactly how these abnormal processes arise is incompletely understood, but evidence suggests that dysregulation of intracellular Ca2+ levels is involved in alterations of neuronal excitability, synaptic remodeling, and neurodegeneration in AD. Our lab has focused on the potential involvement of voltage‐gated potassium channels (VGKCs) in these processes, particularly Kv1.x family members. VGKCs contribute to resting membrane potential, regulate Ca2+ influx, and their inhibition may lead to and synapto‐ and neuro‐toxicity through hyperexcitability and excess glutamate release. Kv1.x family members are expressed as homotetramers, or as select heterotetramers (e.x Kv1.1/1.2) contributing to the diversity of electrical signaling. Previously, we have observed rapid and robust suppression (50% in 30 minutes) of macroscopic current by Aβ(1‐42) in homomeric Kv1.1 expressing Xenopus laevis oocytes. We sought to understand 1) if suppression by Aβ(1‐42) is exclusive to Kv1.1, or is able to affect other Kv1.x members such as homomeric Kv1.2 and heteromeric Kv1.1/1.2 channels 2) The extent to which the suppression is Ca2+ dependent, and 3) whether the suppression is additionally dependent on endogenous tyrosine kinase activity.
Method
Stage V/VI Xenopus laevis oocytes were injected with Kv1.2 cRNA or both Kv1.1 and 1.2 cRNA for homomeric and heteromeric expression respectively. The effects of bath application of 1 μM of Aβ(1‐42) were evaluated using two‐electrode voltage clamp electrophysiology (TEVC), and Ca2+ dependency was evaluated using BAPTA‐AM (a Ca2+ chelator) and Cyclosporin A (CsA; a PP2B inhibitor). Oocytes were additionally incubated in genistein, a non‐specific tyrosine kinase inhibitor.
Result
For both homo‐and heteromeric channel expressing oocytes, incubation in BAPTA‐AM significantly reduced suppression by ∼45%, while incubation with CsA blocked any suppressive effects of Aβ(1‐42). Oocytes incubated in genistein significantly blocked Aβ‐suppression at a level greater than CsA and BAPTA‐AM (>98%).
Conclusion
Reducing intracellular Ca2+ and inhibiting Ca2+ activated signaling molecules such as PP2B and tyrosine kinases reduces suppression of macroscopic Kv1.x current by Aβ(1‐42).</abstract><cop>Hoboken</cop><pub>John Wiley and Sons Inc</pub><doi>10.1002/alz.087563</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1552-5260 |
ispartof | Alzheimer's & dementia, 2024-12, Vol.20 (S1), p.n/a |
issn | 1552-5260 1552-5279 |
language | eng |
recordid | cdi_wiley_primary_10_1002_alz_087563_ALZ087563 |
source | Wiley Online Library Open Access; Wiley Online Library Journals Frontfile Complete; PubMed Central; PubMed Central Open Access |
subjects | Basic Science and Pathogenesis |
title | Calcium‐ and Tyrosine Kinase‐Dependent Suppression of Macroscopic Homomeric Kv1.2 and Heteromeric Kv1.1/1.2 current by Amyloid Beta (1‐42) Peptide: Implications for Alzheimer’s Disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T12%3A32%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Calcium%E2%80%90%20and%20Tyrosine%20Kinase%E2%80%90Dependent%20Suppression%20of%20Macroscopic%20Homomeric%20Kv1.2%20and%20Heteromeric%20Kv1.1/1.2%20current%20by%20Amyloid%20Beta%20(1%E2%80%9042)%20Peptide:%20Implications%20for%20Alzheimer%E2%80%99s%20Disease&rft.jtitle=Alzheimer's%20&%20dementia&rft.au=Jamshidi,%20Dina&rft.date=2024-12&rft.volume=20&rft.issue=S1&rft.epage=n/a&rft.issn=1552-5260&rft.eissn=1552-5279&rft_id=info:doi/10.1002/alz.087563&rft_dat=%3Cwiley_pubme%3EALZ087563%3C/wiley_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |